Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity
- 30 November 1995
- journal article
- research article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 55 (2), 239-246
- https://doi.org/10.1016/0960-0760(95)00171-u
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Characterization of the novel progestin gestodene by receptor binding studies and transactivation assaysContraception, 1995
- Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Estrogenic and progestagenic activities coexisting in steroidal drugs: Quantitative evaluation by In vitro bioassays with human cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cellsEndocrinology, 1993
- Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanismBritish Journal of Cancer, 1993
- One year contraception with a single subdermal implant containing nomegestrol acetate (uniplant)Contraception, 1993
- Intrinsic estrogenicity of some progestagenic drugsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal womenContraception, 1991
- Growth Stimulation and Differential Regulation of Transforming Growth Factor-β1 (TGFβ1), TGFβ2, and TGFβ3 Messenger RNA Levels by Norethindrone in MCF-7 Human Breast Cancer CellsMolecular Endocrinology, 1991
- The effects of the addition of nomegestrol acetate to post-menopausal oestrogen therapyMaturitas, 1989